PROTAGEN AKTIENGESELLSCHAFT

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8198
 
 
 
C07K PEPTIDES 1135
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446
 
 
 
G11B INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER 1137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0074,875 MARKER SEQUENCES FOR DIAGNOSING AND STRATIFYING SLE PATIENTSFeb 10, 15Mar 16, 17[G01N]
2015/0293,120 MARKER SEQUENCES FOR RHEUMATOID ARTHRITISMar 27, 13Oct 15, 15[G01N]
2013/0303,395 MARKER SEQUENCES FOR SYSTEMIC LUPUS ERYTHEMATOSUS AND THE USE THEREOFOct 12, 11Nov 14, 13[G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9588115 Method for the diagnosis of neuromyelitis opticaMar 28, 14Mar 07, 17[G01N, C07K]
9405501 System and method for automatic synchronization of audio layersMay 30, 13Aug 02, 16[G06F, G11B]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0009,300 MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOFAbandonedSep 23, 16Jan 12, 17[C12Q, G01N]
2015/0087,548 MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOFAbandonedNov 03, 14Mar 26, 15[C12Q, G01N]
2014/0371,095 NOVEL METHOD FOR IDENTIFYING SPECIFIC MARKER SEQUENCES FOR PROSTATE CANCERAbandonedNov 14, 12Dec 18, 14[G01N]
2014/0371,098 MARKER SEQUENCES FOR BREAST CANCER AND THE USE THEREOFAbandonedDec 24, 12Dec 18, 14[G01N]
2014/0179,557 MARKER SEQUENCES FOR DIAGNOSING PROSTATE CANCER, AND USE THEREOFAbandonedFeb 24, 14Jun 26, 14[G01N]
2014/0018,245 MARKER SEQUENCES FOR MULTIPLE SCLEROSIS AND USE THEREOFAbandonedOct 12, 11Jan 16, 14[C12N]
2013/0244,897 Marker Sequences for Multiple Sclerosis and Use ThereofAbandonedOct 04, 11Sep 19, 13[C12Q, G01N]
2013/0217,591 Marker Sequences for Inflammatory Prostate Diseases, Prostate Carconoma and Their UseAbandonedApr 10, 13Aug 22, 13[C12Q, G01N]
2013/0029,864 BIOMARKERS FOR ALZHEIMER'S DISEASEAbandonedOct 01, 10Jan 31, 13[C40B]
2012/0264,634 Marker Sequences for Pancreatic Cancer Diseases, Pancreatic Carcinoma and Use ThereofAbandonedSep 29, 10Oct 18, 12[C07H, C12N, G01N, C40B, C07K]
2011/0275,528 MARKER SEQUENCES FOR INFLAMMATORY PROSTATE DISEASES, PROSTATE CARCINOMA AND THEIR USEAbandonedJul 06, 09Nov 10, 11[C40B]
2011/0184,375 MARKER SEQUENCE FOR NEURODEGENERATIVE DISEASES AND THE USE THEREOFAbandonedDec 22, 08Jul 28, 11[C07H, C40B, C07K, A61M]
2010/0331,201 PROTEIN BIOCHIP FOR THE DIFFERENTIAL SCREENING OF PROTEIN-PROTEIN INTERACTIONSAbandonedJun 11, 07Dec 30, 10[C40B]
2010/0280,224 MARKER SEQUENCES FOR MULTIPLE SCLEROSIS AND USE THEREOFAbandonedSep 03, 08Nov 04, 10[C07H, C07K]
2010/0261,881 MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOFAbandonedSep 03, 08Oct 14, 10[C07H, C07K]
2010/0062,059 S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such CompositionsAbandonedApr 20, 07Mar 11, 10[A61K, A61P]
2009/0124,509 Protein-biochip for validating binding agentsAbandonedNov 24, 05May 14, 09[C40B]
2008/0118,515 Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of DiseasesAbandonedJul 15, 04May 22, 08[A61K, C12N, C07K]
2007/0007,875 FLAT PANEL SPACER BASE MATERIAL, METHOD OF MANUFACTURING FLAT PANEL DISPLAY SPACER BASE MATERIAL, FLAT PANEL DISPLAY SPACER, AND FLAT PANEL DISPLAYAbandonedMay 21, 04Jan 11, 07[H01J]
2006/0188,887 Method and system for elucidating the primary structure of biopolymersAbandonedMay 24, 04Aug 24, 06[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.